Daniela Gilardi - Publications

Is it time to introduce health coaching in inflammatory bowel disease management?

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 29, 2025

Combining Advanced Targeted Therapy in Inflammatory Bowel Disease: Current Practice and Future Directions.

Journal: Journal of clinical medicine

Published: December 16, 2024

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn's Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 26, 2022

Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?

Journal: Therapeutic advances in gastroenterology

Published: January 23, 2021

Validation of the Red Flags Index for Early Diagnosis of Crohn's Disease: A Prospective Observational IG-IBD Study Among General Practitioners.

Journal: Journal of Crohn's & colitis

Published: September 29, 2020

Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures.

Journal: The American journal of gastroenterology

Published: August 28, 2020

Endoscopy after surgery in inflammatory bowel disease: Crohn's disease recurrence and pouch surveillance.

Journal: Expert review of gastroenterology & hepatology

Published: August 08, 2020

TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease.

Journal: Current drug targets

Published: July 03, 2020

New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel Diseases.

Journal: Current drug targets

Published: July 02, 2020

Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?

Journal: Current drug targets

Published: June 30, 2020

PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD.

Journal: Expert review of gastroenterology & hepatology

Published: June 24, 2020

Targeting the gut layers in Crohn's disease: mucosal or transmural healing?

Journal: Expert review of gastroenterology & hepatology

Published: June 10, 2020